Aldose Reductase Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Aldose Reductase monoclonal antibodies for research applications. Aldose Reductase Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Aldose reductase is an enzyme involved in the polyol pathway, converting glucose into sorbitol, which plays a significant role in glucose metabolism and osmotic balance within cells. Dysregulation of Aldose Reductase has been implicated in various pathological conditions, including diabetic complications, cataract formation, and neuropathy. Understanding the function and regulation of Aldose Reductase is essential for developing therapeutic strategies targeting these diseases. Researchers studying Aldose Reductase can explore its expression patterns in different tissue types and cellular compartments. Investigating Aldose Reductase activity helps reveal its role in cellular stress responses and metabolic adaptation. Current research focuses on understanding how Aldose Reductase influences disease progression and potential therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of Aldose Reductase and its impact on human health.